Comparative evaluation of occlusal-splint and drug treatments in the management of temporomandibular disorders in a Northern Nigerian population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407847952117

Enrollment

Registered

2024-07-29

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders Musculoskeletal Diseases Oral Health

Interventions

Drugs only

Occlusal splints alone

Drugs with Cognitive Behavioural Therapy

Occlusal splints with Cognitive Behavioural Therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Potential participant must be at least 18 years old 2. Must have active symptoms at presentation 3. Must not have received any treatment for TMD in the past 2 months 4. Must be at least partially dentate with grossly stable occlusion of posterior teeth 5. Must not have radiographic evidence of occlusal trauma or derangement

Exclusion criteria

Exclusion criteria: 1. Edentulous individuals 2. Individuals who wear partial dentures to obtain occlusion of posterior teeth 3. Individuals who have been treated for TMD within 2 months prior to presentation 4. Individuals who regularly take medication that may interfere with results e.g. painkillers, tranquilizers and muscle relaxants. 5. Individuals with radiographic evidence of occlusal trauma or derangement

Design outcomes

Primary

Measure	Time frame
Complete resolution of symptoms	—

Secondary

Measure	Time frame
Optimal occlusal correction and TMJ remodelling	—

Countries

Nigeria

Contacts

Public ContactAdetayo Aborisade

Bayero University Kano.

adetayoaborisade@gmail.com+2348061976332

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026